The challenge of compliance in the life sciences supply chain
In an environment driven by increasing complexity, product diversity and regulatory scrutiny, what are the major compliance risks impacting the entirety of the life sciences supply chain? What opportunities exist to transform compliance from a burden to a source of competitive advantage?
2017 global health care sector outlook
Making progress against persistent challenges
Explore the top issues facing global health care organizations and stakeholders as they seek to address the most challenging issues in 2017.
Facing the tidal wave
De-risking pharma and creating value for patients
The pharmaceutical industry is facing a ‘tidal wave’ of complex age and behaviour-related diseases creating increased economic, scientific and delivery risks. How can pharma companies evolve to overcome these obstacles?
2017 Global life sciences outlook
Thriving in today’s uncertain market
Life sciences sector growth is expected to be fueled by increasing demand from an aging population and the prevalence of chronic and communicable diseases. Learn more in the outlook for 2017.